JP2016527979A5 - - Google Patents

Download PDF

Info

Publication number
JP2016527979A5
JP2016527979A5 JP2016533753A JP2016533753A JP2016527979A5 JP 2016527979 A5 JP2016527979 A5 JP 2016527979A5 JP 2016533753 A JP2016533753 A JP 2016533753A JP 2016533753 A JP2016533753 A JP 2016533753A JP 2016527979 A5 JP2016527979 A5 JP 2016527979A5
Authority
JP
Japan
Prior art keywords
wound
tropoelastin
tropoelastin composition
composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016533753A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016527979A (ja
JP6382311B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2014/050180 external-priority patent/WO2015021508A1/en
Publication of JP2016527979A publication Critical patent/JP2016527979A/ja
Publication of JP2016527979A5 publication Critical patent/JP2016527979A5/ja
Application granted granted Critical
Publication of JP6382311B2 publication Critical patent/JP6382311B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016533753A 2013-08-13 2014-08-13 損傷組織の再生 Active JP6382311B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2013903092A AU2013903092A0 (en) 2013-08-13 Regeneration of damaged tissue
AU2013903092 2013-08-13
PCT/AU2014/050180 WO2015021508A1 (en) 2013-08-13 2014-08-13 Regeneration of damaged tissue

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018145202A Division JP6639587B2 (ja) 2013-08-13 2018-08-01 損傷組織の再生

Publications (3)

Publication Number Publication Date
JP2016527979A JP2016527979A (ja) 2016-09-15
JP2016527979A5 true JP2016527979A5 (enExample) 2017-08-17
JP6382311B2 JP6382311B2 (ja) 2018-08-29

Family

ID=52467858

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016533753A Active JP6382311B2 (ja) 2013-08-13 2014-08-13 損傷組織の再生
JP2018145202A Active JP6639587B2 (ja) 2013-08-13 2018-08-01 損傷組織の再生
JP2019232193A Active JP6891257B2 (ja) 2013-08-13 2019-12-24 損傷組織の再生

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2018145202A Active JP6639587B2 (ja) 2013-08-13 2018-08-01 損傷組織の再生
JP2019232193A Active JP6891257B2 (ja) 2013-08-13 2019-12-24 損傷組織の再生

Country Status (12)

Country Link
US (4) US20160194379A1 (enExample)
EP (2) EP4316537A3 (enExample)
JP (3) JP6382311B2 (enExample)
KR (3) KR102488446B1 (enExample)
CN (2) CN110464837A (enExample)
AU (3) AU2014306362B2 (enExample)
BR (1) BR112016003082A8 (enExample)
CA (1) CA2920312C (enExample)
ES (1) ES2965893T3 (enExample)
MX (2) MX377200B (enExample)
RU (1) RU2677637C2 (enExample)
WO (1) WO2015021508A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9688741B2 (en) 2012-10-23 2017-06-27 Elastagen Pty Ltd Elastic hydrogel
ES2702602T3 (es) 2012-12-10 2019-03-04 Allergan Pharmaceuticals Int Ltd Fabricación de construcciones tridimensionales elásticas escalables
EP4316537A3 (en) 2013-08-13 2024-04-10 Allergan Pharmaceuticals International Limited Regeneration of damaged tissue
AU2016314775A1 (en) * 2015-09-01 2018-03-22 Allergan Pharmaceuticals International Limited Formation of bone
CN110121369A (zh) * 2016-11-04 2019-08-13 艾尔建制药国际有限公司 生物合成装置
CA3136074A1 (en) * 2019-05-03 2020-11-12 Robert Daniels Scar prevention and/or treatment
US20230310552A1 (en) * 2020-09-08 2023-10-05 Protein Genomics Inc. Biomimetic wound healing devices and related methods of treating diabetic wounds

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675387A (en) 1985-07-26 1987-06-23 E. I. Du Pont De Nemours And Company Method for extracting protein with organic acid
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4947840A (en) 1987-08-21 1990-08-14 Massachusetts Institute Of Technology Biodegradable templates for the regeneration of tissues
ATE102631T1 (de) 1988-11-11 1994-03-15 Medical Res Council Klonierung von immunglobulin sequenzen aus den variabelen domaenen.
CA2057014C (en) 1990-03-30 2001-07-24 Toshihiko Kaminuma Process for purification of polypeptide
WO1994007921A1 (en) 1992-09-25 1994-04-14 Commonwealth Scientific And Industrial Research Organisation Target binding polypeptide
NZ258820A (en) * 1992-12-22 1997-07-27 Univ Sydney Recombinant tropoelastins and their preparation
US5726040A (en) 1993-11-10 1998-03-10 Ensley; Burt D. Cosmetic compositions including tropoelastin isomorphs
US7001328B1 (en) * 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO591797A0 (en) 1997-03-27 1997-04-24 Commonwealth Scientific And Industrial Research Organisation High avidity polyvalent and polyspecific reagents
EP0922058A2 (en) 1996-08-07 1999-06-16 Protein Specialities Ltd. Self-aligning peptides derived from elastin and other fibrous proteins
AUPO156596A0 (en) * 1996-08-09 1996-09-05 University Of Sydney, The Synthetic polynucleotides
CA2279902C (en) 1997-02-07 2009-01-13 Sisters Of Providence In Oregon Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
WO1999011196A1 (en) 1997-09-04 1999-03-11 Point Biomedical Corporation Injectable tissue reconstruction material
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
US7109292B2 (en) 1999-03-08 2006-09-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1196510A4 (en) * 1999-05-28 2007-01-17 Providence Health Sys Oregon PROCESSES FOR PRODUCING LAMINATED ELASTIN, ELASTIN-BASED MATERIALS, AND TROPOELASTINE-BASED PRODUCTS FOR REPAIRING AND / OR REPLACING FABRICS
DK1229940T3 (da) 1999-11-15 2014-08-18 Piramal Healthcare Canada Ltd Temperaturstyret og ph-afhængig selvgelerende, vandig biopolymeropløsning
US20050244393A1 (en) 1999-12-22 2005-11-03 Henogen S.A. Sealant or tissue generating product
US6808707B2 (en) * 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
US20040110439A1 (en) 2001-04-20 2004-06-10 Chaikof Elliot L Native protein mimetic fibers, fiber networks and fabrics for medical use
WO2002096978A1 (en) 2001-05-30 2002-12-05 Keiichi Miyamoto Crosslinked elastin and process for producing the same
AU2002952492A0 (en) 2002-11-06 2002-11-21 Cbio Limited Chaperonin 10 immunosuppression
US8383158B2 (en) 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
FR2855969B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee
FR2855968B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de la synthese et de l'activite d'une isoforme de la lysyl oxydase-like loxl pour stimuler la formation de fibres elastiques
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
CA2846382C (en) 2004-02-20 2017-09-19 The Hospital For Sick Children Manganese based compounds for elastogenesis and connective tissue treatment
US7192043B1 (en) 2004-05-25 2007-03-20 Mcluen Design, Inc. Multi-terrain wheel chair
US7968085B2 (en) 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
US20060062768A1 (en) 2004-09-23 2006-03-23 Olexander Hnojewyj Biocompatible hydrogel compositions
WO2006098024A1 (ja) 2005-03-16 2006-09-21 Fujitsu Limited Ipネットワークにおけるマルチキャストツリー監視方法およびシステム
CA2602947A1 (en) 2005-03-24 2006-09-28 Straumann Holding Ag Method for protein purification comprising heat incubation in acetic acidic solution
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
KR100785378B1 (ko) 2005-09-05 2007-12-14 주식회사 바이오레인 다층구조의 유착방지제
US20090169593A1 (en) 2005-10-19 2009-07-02 Biomedical Research Services, Inc. Method of using and producing tropoelastin and tropoelastin biomaterials
US7770126B2 (en) 2006-02-10 2010-08-03 Microsoft Corporation Assisting user interface element use
US8518105B2 (en) 2006-03-24 2013-08-27 Abbott Cardiovascular System Inc. Methods and apparatuses for coating a lesion
US20070237735A1 (en) 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
AU2007285483B2 (en) 2006-05-11 2011-12-22 Regenics As Administration of cells and cellular extracts for rejuvenation
US20070287741A1 (en) 2006-06-13 2007-12-13 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
WO2008033847A2 (en) 2006-09-11 2008-03-20 Emory University Modified protein polymers
US7700126B2 (en) 2006-09-29 2010-04-20 Martin Kean Chong Ng Tropoelastin-based protoelastin biomaterials
BRPI0718615B8 (pt) * 2006-11-13 2021-06-22 Allergan Australia Pty Ltd processo para produzir um material elástico a partir de tropoelastina e material elástico
WO2009015372A1 (en) * 2007-07-25 2009-01-29 Dermaplus, Inc. Photo-protective dermatological formulations and methods of using the same
WO2009018546A1 (en) 2007-08-02 2009-02-05 Medicis Pharmaceutical Corporation Method of applying an injectable filler
FR2920968B1 (fr) 2007-09-14 2009-11-13 Oreal Procede cosmetique de traitement esthetique et/ou reparateur de la peau
US9421305B2 (en) 2008-02-01 2016-08-23 Wake Forest University Health Sciences Aligned scaffolding system for skeletal muscle regeneration
US8469961B2 (en) 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US8940331B2 (en) 2008-11-22 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells
US8080265B2 (en) 2009-02-20 2011-12-20 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating signs of skin aging
EP3881825B1 (en) * 2009-03-10 2024-12-25 Allergan Pharmaceuticals International Limited Injectable biomaterials
PL2550027T5 (pl) 2010-03-22 2019-07-31 Allergan, Inc. Polisacharydowe i białkowo-polisacharydowe usieciowane hydrożele do powiększania tkanek miękkich
WO2011127478A1 (en) 2010-04-09 2011-10-13 Nanovasc, Inc. Sleeve for graft and method
US8658711B2 (en) 2010-09-29 2014-02-25 Rutgers, The State University Of New Jersey Process for the synthesis of methacrylate-derivatized type-1 collagen and derivatives thereof
EP4043043A1 (en) 2010-11-23 2022-08-17 Allergan Pharmaceuticals International Limited Preparation and/or formulation of proteins cross-linked with polysaccharides
GB201021438D0 (en) 2010-12-16 2011-02-02 Imp Innovations Ltd Layered fibrous construct
US9114128B2 (en) * 2011-09-30 2015-08-25 Protein Genomics, Inc. Tropoelastins and uses thereof
EP3505180B1 (en) 2011-09-30 2022-08-03 Allergan Pharmaceuticals International Limited In vivo synthesis of elastic fiber
US9688741B2 (en) * 2012-10-23 2017-06-27 Elastagen Pty Ltd Elastic hydrogel
ES2702602T3 (es) 2012-12-10 2019-03-04 Allergan Pharmaceuticals Int Ltd Fabricación de construcciones tridimensionales elásticas escalables
EP4316537A3 (en) * 2013-08-13 2024-04-10 Allergan Pharmaceuticals International Limited Regeneration of damaged tissue
KR20200138836A (ko) 2013-09-24 2020-12-10 앨러간 파마슈티컬스 인터내셔널 리미티드 단백질 추출 방법

Similar Documents

Publication Publication Date Title
JP2016527979A5 (enExample)
JP2018164789A5 (enExample)
RU2016104618A (ru) Регенерация поврежденной ткани
JP2012006971A5 (enExample)
HK1214765A1 (zh) 包含b-raf抑制剂和组蛋白脱乙酰基酶抑制剂的药物组合以及其在治疗增生性疾病中的用途
EP4445922A3 (en) Bioresorbable dressing with structural support
WO2017163132A3 (en) Use of umbilical cord blood derived exosomes for tissue repair
JP2014218522A5 (enExample)
GB2535117A (en) A ready to use biodegradable and biocompatable device and a method of preparation thereof
EP4474011A3 (en) High elasticity hyaluronan compositions and methods of use thereof
EP3606570B8 (en) Collagen peptide-based medicament compositions for use in the treatment of ocular diseases, disorders or wounds
IL284338A (en) Anti-cd40 antibodies for use in treatment of hidradenitis suppurativa
TN2015000520A1 (en) Pharmaceutical compositions comprising collagen and sodium hyaluronate
PH12016500751A1 (en) Spray-on burn dressing
IL273329A (en) Modulation of hepatic-hepatic epidermal growth factor activity to heal the eardrum membrane
HUE049556T2 (hu) Szolúbilis fibroblaszt növekedési faktor receptor 3 (sFGFR3) polipeptid, vázszerkezetinövekedés-retardációs rendellenességek megelõzésében vagy kezelésében történõ alkalmazásra
WO2018094023A3 (en) Cyclic dipeptides and wound healing
CL2014001556A1 (es) Método para identificar compuestos inhibidores específicos de hemicanales de conexina y uso de dichos inhibidores para tratar y/o prevenir enfermedades inflamatorias, desórdenes vasculares, arritmia, heridas crónicas, neuroprotección de retina, fibrosis y dolor.
JP2017513944A5 (enExample)
JP2018500094A5 (enExample)
CO2019008657A2 (es) Composición intranasal que comprende betahistina
JP2017513945A5 (enExample)
AU2014365665A1 (en) Use of PAR-1 antagonists for preventing and/or treating pelvi-perineal functional pathological conditions
AU2014216273A8 (en) Topical ocular analgesic agents
CA3054005C (en) Antiseptic composition comprising unithiol and dimethylsulfoxide, use of the composition and method of wound treatment with its use